Ratings by Barclays (Glen Santangelo)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/21/2026 | GoodRx Holdings Inc. | GDRX | Maintain | Underweight (N/A) |
|
Details | ||
| 8/21/2026 | Doximity Inc | DOCS | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/21/2026 | Claritev | CTEV | Maintain | Overweight (N/A) |
|
Details | ||
| 8/20/2026 | Hims and Hers | HIMS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/19/2026 | McKesson | MCK | Maintain | Overweight (N/A) |
|
Details | ||
| 8/19/2026 | Collegium Pharmaceutical | COLL | Maintain | Overweight (N/A) |
|
Details | ||
| 8/19/2026 | Amphastar Pharmaceuticals | AMPH | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/17/2026 | Phathom Pharmaceuticals | PHAT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/13/2026 | Cardinal Health | CAH | Maintain | Overweight (N/A) |
|
Details | ||
| 8/12/2026 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 8/11/2026 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2026 | Henry Schein | HSIC | Maintain | Overweight (N/A) |
|
Details | ||
| 8/5/2026 | Indivior | INDV | Maintain | Overweight (N/A) |
|
Details | ||
| 7/14/2026 | Lifestance Health Group | LFST | Maintain | Overweight (N/A) |
|
Details | ||
| 7/1/2026 | Zoetis Inc. | ZTS | Maintain | Equalweight (N/A) |
|
Details | ||
| 6/18/2026 | Indivior | INDV | New Coverage | Overweight (N/A) |
38.01 (34.94) |
-8.08% | Details | |
| 6/17/2026 | Hims and Hers | HIMS | Maintain | Overweight (N/A) |
|
Details | ||
| 6/11/2026 | Envista Holdings Corp. | NVST | Maintain | Overweight (N/A) |
|
Details | ||
| 6/10/2026 | McKesson | MCK | Maintain | Overweight (N/A) |
|
Details | ||
| 6/10/2026 | Cencora Inc | COR | Maintain | Overweight (N/A) |
|
Details | ||
| 6/3/2026 | Amphastar Pharmaceuticals | AMPH | Maintain | Equalweight (N/A) |
|
Details | ||
| 6/1/2026 | Medline Inc | MDLN | Maintain | Overweight (N/A) |
|
Details | ||
| 5/29/2026 | Medline Inc | MDLN | Maintain | Overweight (N/A) |
|
Details | ||
| 5/20/2026 | Amneal Pharmaceuticals | AMRX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/19/2026 | Viatris | VTRS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/18/2026 | Progyny | PGNY | Maintain | Overweight (N/A) |
|
Details | ||
| 5/14/2026 | Phreesia Inc. | PHR | Downgrade | Equalweight (Overweight) |
9.19 (10.94) |
19.04% | Details | |
| 5/14/2026 | Doximity Inc | DOCS | Downgrade | Equalweight (Overweight) |
23.39 (26.35) |
12.65% | Details | |
| 5/6/2026 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 4/24/2026 | Claritev | CTEV | New Coverage | Overweight (N/A) |
21.91 (38.43) |
75.4% | Details | |
| 4/8/2026 | Amphastar Pharmaceuticals | AMPH | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/27/2026 | Phathom Pharmaceuticals | PHAT | Upgrade | Overweight (Equalweight) |
10.47 (9.50) |
-9.26% | Details | |
| 3/26/2026 | Teladoc | TDOC | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/23/2026 | Alvotech SA | ALVO | Maintain | Underweight (N/A) |
|
Details | ||
| 3/23/2026 | Viatris | VTRS | Maintain | Overweight (N/A) |
|
Details | ||
| 3/19/2026 | Progyny | PGNY | Maintain | Overweight (N/A) |
|
Details | ||
| 3/19/2026 | Collegium Pharmaceutical | COLL | Maintain | Overweight (N/A) |
|
Details | ||
| 3/19/2026 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 3/18/2026 | ANI Pharmaceuticals | ANIP | Maintain | Overweight (N/A) |
|
Details | ||
| 3/17/2026 | Align Technology | ALGN | Upgrade | Overweight (Equalweight) |
164.23 (158.64) |
-3.4% | Details | |
| 3/11/2026 | Hims and Hers | HIMS | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/9/2026 | TalkSpace | TALK | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/6/2026 | Lifestance Health Group | LFST | Maintain | Overweight (N/A) |
|
Details | ||
| 2/26/2026 | Align Technology | ALGN | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/25/2026 | Hims and Hers | HIMS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/25/2026 | Bausch Health Companies | BHC | Maintain | Equalweight (Equalweight) |
|
Details | ||
| 2/24/2026 | Organon & Co. | OGN | Maintain | Underweight (N/A) |
|
Details | ||
| 2/24/2026 | Cardinal Health | CAH | Maintain | Overweight (N/A) |
|
Details | ||
| 2/23/2026 | TalkSpace | TALK | Maintain | Equalweight (Equalweight) |
|
Details | ||
| 2/18/2026 | McKesson | MCK | Maintain | Overweight (N/A) |
|
Details | ||
| 2/18/2026 | HealthEquity, Inc | HQY | Maintain | Overweight (N/A) |
|
Details | ||
| 2/13/2026 | Cencora Inc | COR | Maintain | Overweight (N/A) |
|
Details | ||
| 2/11/2026 | Envista Holdings Corp. | NVST | Maintain | Overweight (N/A) |
|
Details | ||
| 2/11/2026 | Doximity Inc | DOCS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/5/2026 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/30/2026 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 1/12/2026 | Medline Inc | MDLN | New Coverage | Overweight (N/A) |
41.25 (36.59) |
-11.3% | Details | |
| 1/9/2026 | Collegium Pharmaceutical | COLL | Maintain | Overweight (Overweight) |
|
Details | ||
| 12/16/2025 | Phreesia Inc. | PHR | Maintain | Overweight (N/A) |
|
Details | ||
| 12/9/2025 | Organon & Co. | OGN | New Coverage | Underweight (N/A) |
7.14 (13.78) |
93% | Details | |
| 12/9/2025 | Collegium Pharmaceutical | COLL | New Coverage | Overweight (N/A) |
47.91 (23.53) |
-50.89% | Details | |
| 12/9/2025 | Amphastar Pharmaceuticals | AMPH | New Coverage | Equalweight (N/A) |
26.77 (23.18) |
-13.41% | Details | |
| 12/9/2025 | Phathom Pharmaceuticals | PHAT | New Coverage | Equalweight (N/A) |
14.58 (9.50) |
-34.84% | Details | |
| 12/9/2025 | Teva Pharma | TEVA | New Coverage | Overweight (N/A) |
28.46 (36.36) |
27.76% | Details | |
| 12/9/2025 | Amneal Pharmaceuticals | AMRX | New Coverage | Overweight (N/A) |
12.18 (17.44) |
43.19% | Details | |
| 12/9/2025 | Tarsus Pharmaceuticals | TARS | New Coverage | Overweight (N/A) |
81.77 (90.78) |
11.02% | Details | |
| 12/9/2025 | Alvotech SA | ALVO | New Coverage | Underweight (N/A) |
5.47 (5.32) |
-2.74% | Details | |
| 12/9/2025 | Viatris | VTRS | New Coverage | Overweight (N/A) |
10.93 (16.88) |
54.44% | Details | |
| 12/9/2025 | Pacira Pharmaceuticals | PCRX | New Coverage | Equalweight (N/A) |
23.99 (26.35) |
9.84% | Details | |
| 12/9/2025 | Bausch Health Companies | BHC | New Coverage | Equalweight (N/A) |
6.93 (6.56) |
-5.34% | Details | |
| 12/9/2025 | Elanco Animal Health | ELAN | New Coverage | Overweight (N/A) |
21.90 (24.50) |
11.87% | Details | |
| 12/9/2025 | Teladoc | TDOC | New Coverage | Equalweight (N/A) |
7.59 (6.28) |
-17.26% | Details | |
| 12/9/2025 | Progyny | PGNY | New Coverage | Overweight (N/A) |
24.02 (31.19) |
29.85% | Details | |
| 12/9/2025 | Phreesia Inc. | PHR | New Coverage | Overweight (N/A) |
20.29 (10.94) |
-46.08% | Details | |
| 12/9/2025 | TalkSpace | TALk | New Coverage | Equalweight (N/A) |
3.08 (5.25) |
70.45% | Details | |
| 12/9/2025 | Zoetis Inc. | ZTS | New Coverage | Equalweight (N/A) |
118.65 (75.81) |
-36.11% | Details | |
| 12/9/2025 | Henry Schein | HSIC | New Coverage | Overweight (N/A) |
73.62 (89.81) |
21.99% | Details | |
| 12/9/2025 | Envista Holdings Corp. | NVST | New Coverage | Overweight (N/A) |
20.23 (27.28) |
34.85% | Details | |
| 12/9/2025 | IDEXX Laboratories | IDXX | New Coverage | Overweight (N/A) |
714.10 (535.38) |
-25.03% | Details | |
| 12/9/2025 | Cencora Inc | COR | New Coverage | Overweight (N/A) |
339.66 (330.95) |
-2.56% | Details | |
| 12/9/2025 | Cardinal Health | CAH | New Coverage | Overweight (N/A) |
198.83 (247.18) |
24.32% | Details | |
| 12/9/2025 | Lifestance Health Group | LFST | New Coverage | Overweight (N/A) |
6.48 (12.73) |
96.45% | Details | |
| 12/9/2025 | GoodRx Holdings Inc. | GDRX | New Coverage | Underweight (N/A) |
2.71 (3.48) |
28.41% | Details | |
| 12/9/2025 | McKesson | MCK | New Coverage | Overweight (N/A) |
808.62 (907.99) |
12.29% | Details | |
| 12/9/2025 | HealthEquity, Inc | HQY | New Coverage | Overweight (N/A) |
94.51 (96.07) |
1.65% | Details | |
| 12/9/2025 | Doximity Inc | DOCS | New Coverage | Overweight (N/A) |
45.93 (26.35) |
-42.63% | Details | |
| 12/9/2025 | Align Technology | ALGN | New Coverage | Equalweight (N/A) |
157.21 (164.23) |
4.47% | Details |
